Pipark-T 1.125

Description

Pipark-T 1.125 Injection is a highly effective antibiotic combination containing Piperacillin (1000 mg) and Tazobactam (125 mg). This formulation is widely used in hospitals to manage moderate to severe bacterial infections. Piperacillin works by destroying bacterial cell walls, while Tazobactam prevents bacterial resistance, enhancing the antibiotic’s overall effectiveness.

Key Uses

• Respiratory tract infections
• Urinary tract infections (UTIs)
• Intra-abdominal infections
• Skin and soft tissue infections
• Bloodstream infections (septicemia)

Key Benefits

• Broad-spectrum antibacterial coverage
• Effective against resistant bacteria
• Fast action via intravenous administration
• Trusted in ICU and critical care settings
• Enhanced efficacy due to combination therapy

This injection is administered under medical supervision, ensuring controlled dosage and rapid response. The sterile vial packaging guarantees safety and maintains drug stability, making it suitable for hospital environments.

Precautions

• Use only under a doctor’s guidance
• Complete the full prescribed course
• Inform your doctor about allergies
• Avoid misuse to prevent antibiotic resistance

In summary, Pipark-T 1.125 Injection is a reliable and powerful antibiotic choice for serious infections. Its dual-action formula ensures better bacterial control and faster recovery, making it a preferred option in modern healthcare.